0,854  0,009  Antiinflammatory
0,803  0,016  Apoptosis agonist
0,737  0,005  Antineurogenic pain
0,731  0,007  Sensitization
0,710  0,005  Nitric oxide antagonist
0,706  0,004  P-glycoprotein inhibitor
0,702  0,013  Antileukemic
0,632  0,005  Antineoplastic enhancer
0,637  0,021  Analgesic
0,615  0,011  Immunosuppressant
0,626  0,031  Antineoplastic (breast cancer)
0,577  0,013  Cardiovascular analeptic
0,546  0,014  Antifungal
0,552  0,037  Transcription factor NF kappa B inhibitor
0,523  0,008  UGT1A4 substrate
0,513  0,004  Antifungal enhancer
0,515  0,011  Angiogenesis stimulant
0,524  0,024  CYP2C19 substrate
0,506  0,021  Antineoplastic (pancreatic cancer)
0,496  0,028  Bone diseases treatment
0,504  0,035  CYP2C9 substrate
0,508  0,044  TNF expression inhibitor
0,482  0,023  Antiosteoporotic
0,486  0,030  Respiratory analeptic
0,476  0,021  NOS2 expression inhibitor
0,472  0,020  Antiprotozoal (Leishmania)
0,445  0,006  Antialcoholic
0,465  0,028  Spasmolytic
0,441  0,005  Acaricide
0,453  0,022  ICAM1 expression inhibitor
0,484  0,054  Alzheimer's disease treatment
0,466  0,043  Antipruritic, allergic
0,431  0,011  Contraceptive
0,418  0,012  Antiparkinsonian, rigidity relieving
0,422  0,022  Antiparasitic
0,427  0,038  FMO1 substrate
0,409  0,020  Myocardial infarction treatment
0,396  0,008  Protein kinase stimulant
0,463  0,076  Caspase 9 stimulant
0,406  0,022  Antineoplastic (liver cancer)
0,447  0,064  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,392  0,012  Antiacne
0,396  0,017  Antihelmintic
0,408  0,034  Antineoplastic (glioma)
0,430  0,058  Antineoplastic (lung cancer)
0,387  0,017  5 Hydroxytryptamine uptake stimulant
0,401  0,038  Analeptic
0,389  0,030  Antineoplastic (glioblastoma multiforme)
0,363  0,004  ATPase inhibitor
0,360  0,017  Antiviral (Influenza)
0,352  0,014  Prostate disorders treatment
0,344  0,012  Antiviral (Influenza A)
0,364  0,033  Antiglaucomic
0,369  0,039  Calcium channel activator
0,347  0,019  Antihypotensive
0,369  0,045  Antiepileptic
0,346  0,026  Abortion inducer
0,366  0,049  Antineoplastic (melanoma)
0,320  0,004  Vanilloid agonist
0,349  0,036  Antidiabetic symptomatic
0,321  0,016  Cholinergic
0,326  0,021  Skin irritative effect
0,358  0,054  Antipsoriatic
0,358  0,059  Antineoplastic (colon cancer)
0,361  0,062  Antineoplastic (colorectal cancer)
0,343  0,044  Antineoplastic (multiple myeloma)
0,349  0,052  Radioprotector
0,348  0,053  Antineoplastic (brain cancer)
0,330  0,035  Interleukin agonist
0,316  0,023  UGT2B7 substrate
0,341  0,053  Teratogen
0,344  0,059  Antineoplastic (ovarian cancer)
0,289  0,004  Cannabinoid CB2 receptor antagonist
0,311  0,031  Sedative
0,304  0,024  VCAM1 expression inhibitor
0,328  0,051  UGT2B4 substrate
0,327  0,050  Chemoprotective
0,332  0,056  CTGF expression inhibitor
0,353  0,077  CYP3A4 substrate
0,293  0,020  Neurotrophic factor enhancer
0,308  0,041  Chemopreventive
0,290  0,025  Diabetic retinopathy treatment
0,287  0,023  Anesthetic
0,271  0,009  Farnesoid X receptor antagonist
0,270  0,008  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,282  0,024  Melanin inhibitor
0,300  0,043  Psychostimulant
0,261  0,004  Actinic keratosis treatment
0,293  0,042  Transplant rejection treatment
0,299  0,050  Vascular (periferal) disease treatment
0,294  0,045  DNA synthesis inhibitor
0,307  0,059  Antioxidant
0,270  0,022  UGT2B15 substrate
0,322  0,076  Antithrombotic
0,254  0,009  Antifungal (Cryptococcus)
0,303  0,058  Embryotoxic
0,297  0,053  Antineoplastic (renal cancer)
0,281  0,037  UGT1A1 substrate
0,294  0,052  GST M1-1 substrate
0,308  0,067  5 Hydroxytryptamine release stimulant
0,289  0,053  Cytotoxic
0,243  0,010  Microtubule formation inhibitor
0,265  0,034  Pneumotoxic
0,286  0,055  Cytostatic
0,250  0,020  UGT2B9 substrate
0,295  0,066  FMO3 substrate
0,233  0,004  Antihypermotility
0,256  0,027  Interferon gamma antagonist
0,248  0,021  Acetylcholinesterase inhibitor
0,274  0,050  Carcinogenic
0,280  0,059  Proliferative diseases treatment
0,234  0,014  Antismoking
0,229  0,010  Contraceptive female
0,224  0,007  TRPA1 agonist
0,250  0,035  Antipruritic, non-allergic
0,259  0,045  RNA-directed DNA polymerase inhibitor
0,283  0,071  Antihypoxic
0,313  0,106  Antineoplastic (myeloid leukemia)
0,245  0,039  CYP2B6 inhibitor
0,323  0,118  Antibacterial
0,222  0,024  UGT2B10 substrate
0,288  0,090  AR expression inhibitor
0,231  0,034  Hair growth stimulant
0,254  0,058  Antimitotic
0,243  0,051  UDP-glucuronosyltransferase substrate
0,247  0,061  Antiulcerative
0,306  0,121  CYP2C19 inhibitor
0,224  0,043  Lipocortins synthesis antagonist
0,190  0,009  Cannabinoid receptor antagonist
0,219  0,040  Antiviral (Herpes)
0,187  0,009  Postmenopausal disorders treatment
0,275  0,097  Prostate cancer treatment
0,222  0,045  Prostatic (benign) hyperplasia treatment
0,254  0,079  Flavin-containing monooxygenase substrate
0,203  0,030  Arachidonic acid antagonist
0,224  0,052  Hepatoprotectant
0,178  0,008  Anabolic
0,194  0,028  Cholesterol synthesis inhibitor
0,177  0,011  Inducible nitric-oxide synthase inhibitor
0,200  0,039  Antirickettsial
0,187  0,026  Retinoprotector
0,209  0,048  Eye irritation, high
0,210  0,051  Antimutagenic
0,169  0,010  Cannabinoid receptor agonist
0,167  0,008  Ornithine decarboxylase inhibitor
0,275  0,122  Ulceration
0,179  0,027  Adenylate cyclase stimulant
0,163  0,012  Aromatase inhibitor
0,160  0,009  Cannabinoid CB2 receptor agonist
0,175  0,026  Growth stimulant
0,273  0,126  GST A substrate
0,161  0,014  Transcription factor NF kappa B stimulant
0,248  0,101  CYP1A2 substrate
0,172  0,026  Antineoplastic antibiotic
0,149  0,004  Sphingosine 1-phosphate receptor 3 agonist
0,162  0,021  Ca2+-transporting ATPase inhibitor
0,194  0,053  Antihelmintic (Nematodes)
0,208  0,067  Platelet adhesion inhibitor
0,160  0,020  Androgen antagonist
0,181  0,043  Carcinogenic, group 3
0,233  0,097  Amyotrophic lateral sclerosis treatment
0,145  0,009  ATPase (Vacuolar H+) inhibitor
0,250  0,115  Immunomodulator
0,139  0,003  Postcoital contraceptive
0,223  0,088  Antineoplastic (cervical cancer)
0,162  0,028  Vanilloid 1 agonist
0,145  0,012  Tourette's syndrome treatment
0,200  0,071  Non-steroidal antiinflammatory agent
0,198  0,069  Mutagenic
0,231  0,103  Gastrin inhibitor
0,168  0,040  DNA polymerase I inhibitor
0,184  0,057  Antianorexic
0,220  0,094  Antipyretic
0,251  0,125  Cholesterol antagonist
0,130  0,004  CXC chemokine 3 receptor antagonist
0,137  0,012  Cannabinoid CB1 receptor agonist
0,218  0,094  Tumour necrosis factor alpha release inhibitor
0,133  0,009  Glycine receptor agonist
0,217  0,095  Antihypercholesterolemic
0,155  0,034  Menstruation disorders treatment
0,263  0,143  GABA C receptor rho-3 antagonist
0,140  0,020  UGT2B11 substrate
0,159  0,042  Protein-tyrosine phosphatase 1B inhibitor
0,181  0,067  Muscle relaxant
0,137  0,024  GST T1-1 substrate
0,147  0,034  Choleretic
0,146  0,036  Alcohol dehydrogenase substrate
0,123  0,014  Na+ K+ transporting ATPase inhibitor
0,115  0,006  Sphingosine 1-phosphate receptor 5 agonist
0,162  0,054  SULT1A3 substrate
0,152  0,048  Anesthetic local
0,224  0,122  CYP2D6 substrate
0,114  0,012  Cannabinoid CB1 receptor antagonist
0,141  0,040  SULT1A1 substrate
0,128  0,027  Acetylcholine nicotinic antagonist
0,155  0,054  Neurotrophic factor
0,283  0,185  5 Hydroxytryptamine release inhibitor
0,154  0,060  CNS active muscle relaxant
0,127  0,035  Antineoplastic alkaloid
0,101  0,010  5-Alpha-reductase inhibitor
0,125  0,035  Nitric-oxide synthase inhibitor
0,137  0,048  Antiviral (Papilloma)
0,118  0,029  Antidote, mercury
0,103  0,014  Androgen agonist
0,154  0,066  Hearing loss treatment
0,173  0,085  Antiviral (Hepatitis)
0,096  0,008  Nicotinic alpha3beta2 receptor antagonist
0,169  0,082  Succinate dehydrogenase inhibitor
0,110  0,023  Nicotinic alpha4beta2 receptor antagonist
0,167  0,080  Phobic disorders treatment
0,102  0,015  Vanilloid 4 agonist
0,144  0,058  Alpha-N-acetylglucosaminidase inhibitor
0,117  0,033  ABCA1 expression enhancer
0,128  0,045  GABA C receptor antagonist
0,129  0,048  Ferrochelatase inhibitor
0,150  0,070  Movement disorders treatment
0,105  0,025  Thioredoxin reductase inhibitor
0,205  0,126  Tyrosine 3 hydroxylase inhibitor
0,097  0,020  Bcl2 antagonist
0,156  0,080  Interleukin 6 antagonist
0,180  0,106  5 Hydroxytryptamine 3E antagonist
0,219  0,144  Caspase 3 stimulant
0,089  0,015  SULT2A1 substrate
0,122  0,048  GABA C receptor agonist
0,098  0,026  Narcotic antagonist
0,115  0,042  Prolactin inhibitor
0,150  0,078  Protein-tyrosine phosphatase inhibitor
0,183  0,111  UGT1A6 substrate
0,198  0,130  UGT1A9 substrate
0,095  0,027  Neuronal nicotinic receptor antagonist
0,073  0,006  Parathyroid hormone antagonist
0,074  0,009  Retinoid X receptor agonist
0,184  0,119  Antineoplastic (non-small cell lung cancer)
0,071  0,006  Microtubule stabilization
0,071  0,007  GABA uptake inhibitor
0,104  0,041  Bile acid receptor antagonist
0,123  0,060  Antiviral (Influenza B)
0,079  0,016  Heme oxygenase stimulant
0,080  0,017  Nicotinic receptor alpha7 subunit antagonist
0,082  0,020  Transcription factor AP-1 inhibitor
0,066  0,004  Tubulin agonist
0,129  0,067  Antiseptic
0,074  0,013  Anesthetic inhalation
0,123  0,063  Proteasome inhibitor
0,207  0,147  Hepatic disorders treatment
0,093  0,033  GABA aminotransferase inhibitor
0,089  0,029  Antidote, organophosphates
0,064  0,005  Retinoid X receptor antagonist
0,116  0,058  Myasthenia Gravis treatment
0,078  0,020  Protein 50S ribosomal subunit inhibitor
0,080  0,023  Estrogen agonist
0,060  0,005  Vanilloid 3 antagonist
0,121  0,066  Beta amyloid protein antagonist
0,091  0,037  Keratolytic
0,174  0,120  Aldehyde oxidase inhibitor
0,067  0,014  Adenylate cyclase 1 inhibitor
0,126  0,072  Antihyperlipoproteinemic
0,217  0,165  Sodium/bile acid cotransporter inhibitor
0,068  0,016  Pregnane X receptor antagonist
0,146  0,095  Antiviral (Hepatitis C)
0,055  0,005  Retinoid X alpha receptor antagonist
0,050  0,003  Progesterone receptor B antagonist
0,100  0,054  Posttraumatic stress disorder treatment
0,155  0,109  Anesthetic general
0,134  0,088  Genotoxic
0,073  0,028  Antimycoplasmal
0,097  0,052  Antithrombocytopenic
0,054  0,009  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,093  0,049  Tocolytic
0,106  0,062  Expectorant
0,111  0,068  Aldehyde dehydrogenase substrate
0,047  0,004  Nicotinic acid receptor 2 antagonist
0,074  0,032  Glutamate (mGluR6) antagonist
0,212  0,169  Interleukin 2 agonist
0,114  0,072  Transcription factor STAT6 inhibitor
0,196  0,155  NOS3 expression inhibitor
0,053  0,011  Kainate receptor agonist
0,075  0,033  CDC25B inhibitor
0,118  0,077  Sphingosine 1-phosphate receptor 4 antagonist
0,104  0,064  Carcinogenic, group 2B
0,083  0,044  Antibiotic
0,111  0,071  Antitussive
0,043  0,004  Vanilloid 2 agonist
0,115  0,076  Antifungal (Pneumocystis)
0,084  0,045  CYP2A6 inhibitor
0,052  0,013  Retinoic acid alpha receptor agonist
0,064  0,026  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,078  0,040  CXC chemokine receptor antagonist
0,058  0,021  Aldosterone antagonist
0,149  0,112  LDLR expression enhancer
0,132  0,095  Pregnane X receptor agonist
0,053  0,016  Estrogen receptor alpha agonist
0,086  0,050  Estrogen-related receptor beta agonist
0,051  0,015  Alpha 1L adrenoreceptor agonist
0,085  0,049  Glycine receptor antagonist
0,152  0,116  Sepsis treatment
0,124  0,089  Antiparkinsonian, tremor relieving
0,049  0,014  Nicotinic acid receptor 2 agonist
0,084  0,050  Sleep apnea treatment
0,102  0,071  Antifungal (Aspergillus)
0,037  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,040  0,012  Adenosine uptake inhibitor
0,050  0,021  Guanylate cyclase inhibitor
0,081  0,053  Chymotrypsin inhibitor
0,072  0,044  Anticholelithogenic
0,061  0,034  Lipocortins synthesis agonist
0,046  0,020  Progesterone antagonist
0,043  0,017  Retinoid X alpha receptor agonist
0,034  0,008  Retinoic acid receptor agonist
0,107  0,081  Autism spectrum disorders treatment
0,083  0,058  Antispirochetal
0,135  0,111  Carcinogenic, group 1
0,036  0,013  Nicotinic alpha3beta4 receptor agonist
0,114  0,091  Bone formation stimulant
0,158  0,135  Antineoplastic (lymphoma)
0,152  0,130  Insulin sensitizer
0,098  0,076  Excitatory amino acid transporter EAAC1 inhibitor
0,063  0,041  Prolactin release inhibitor
0,111  0,089  Coagulant
0,093  0,072  Antifungal (Candida)
0,053  0,032  Prolyl endopeptidase inhibitor
0,026  0,005  NMDA receptor phencyclidine site antagonist
0,028  0,008  Retinoic acid gamma receptor agonist
0,094  0,073  Glutathione S-transferase substrate
0,126  0,106  UGT1A3 substrate
0,029  0,009  5-Alpha-reductase 1 inhibitor
0,036  0,017  ATP citrate lysase inhibitor
0,029  0,011  Retinoid X gamma receptor agonist
0,026  0,008  Progesterone agonist
0,096  0,078  UGT2B1 substrate
0,039  0,022  Nicotinic acid receptor agonist
0,030  0,013  Retinoid X gamma receptor antagonist
0,052  0,035  Aconitate hydratase inhibitor
0,063  0,046  Interferon inducer
0,024  0,008  Retinoid X beta receptor antagonist
0,147  0,133  Anticonvulsant
0,024  0,010  Retinoic acid alpha receptor antagonist
0,025  0,010  Vitamin D receptor antagonist
0,023  0,009  Retinoic acid receptor antagonist
0,030  0,017  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,068  0,054  Benzodiazepine agonist
0,017  0,004  Progesterone receptor A antagonist
0,022  0,010  Retinoic acid beta receptor agonist
0,023  0,011  5-Alpha-reductase 2 inhibitor
0,019  0,009  Telomerase stimulant
0,031  0,021  RNA-directed RNA polymerase stimulant
0,073  0,064  Interferon agonist
0,079  0,069  T cell inhibitor
0,064  0,055  Glutamate (mGluR7) antagonist
0,047  0,038  HCV NS3/NS4A protease inhibitor
0,084  0,076  Glutamate release inhibitor
0,121  0,113  Sigma receptor agonist
0,059  0,051  Hyperparathyroidism treatment
0,040  0,033  Sphingosine 1-phosphate receptor 1 agonist
0,041  0,034  Nicotinic receptor alpha3 subunit antagonist
0,120  0,114  Heat shock protein 90 antagonist
0,021  0,015  Retinoid X beta receptor agonist
0,076  0,071  Acetylcholine agonist
0,088  0,083  Antiviral (Poxvirus)
0,036  0,031  Alpha 1d adrenoreceptor agonist
0,016  0,011  Prostacyclin agonist
0,090  0,086  Antiprotozoal (Toxoplasma)
0,028  0,024  Estrogen receptor beta agonist
0,190  0,186  Multiple sclerosis treatment
0,066  0,063  Acetylcholine M4 receptor antagonist
0,091  0,088  Toll-Like receptor 4 antagonist
0,049  0,046  Alpha-mannosidase inhibitor
0,086  0,085  GABA C receptor rho-1 antagonist
0,021  0,019  CYP24 inhibitor
0,189  0,188  CYP3A4 inhibitor
0,015  0,014  Vitamin D receptor agonist
0,020  0,019  GRP78 expression inhibitor
0,062  0,061  Hypercalcemia treatment
0,026  0,025  Hedgehog signaling activator

